EP 2590979 A1 20130515 - RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES
Title (en)
RING-FUSED PYRIMIDINES AND TRIAZINES AND USE THEREOF FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES
Title (de)
ANNELLIERTE PYRIMIDINE UND TRIAZINE UND IHRE VERWENDUNG ZUR BEHANDLUNG BZW. PROPHYLAXE VON HERZ-KREISLAUF-ERKRANKUNGEN
Title (fr)
PYRIMIDINES ET TRIAZINES ANNELÉES ET LEUR UTILISATION POUR TRAITER OU PRÉVENIR DES AFFECTIONS DU SYSTÈME CARDIO-VASCULAIRE
Publication
Application
Priority
- DE 102011003315 A 20110128
- DE 102010031149 A 20100709
- EP 2011061305 W 20110705
Abstract (en)
[origin: WO2012004258A1] The invention relates to novel ring-fused pyrimidines and triazines, to methods for the production thereof, use thereof on its own or combined for the treatment and/or prophylaxis of diseases and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.
IPC 8 full level
C07D 487/04 (2006.01); A61K 31/519 (2006.01); A61K 31/522 (2006.01); A61P 9/00 (2006.01)
CPC (source: CN EP KR US)
A61K 31/519 (2013.01 - EP KR US); A61K 31/527 (2013.01 - EP US); A61K 31/53 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 7/00 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 13/12 (2017.12 - EP); C07D 471/04 (2013.01 - CN EP US); C07D 487/04 (2013.01 - EP KR US); C07D 491/107 (2013.01 - EP US); C07D 519/00 (2013.01 - CN)
Citation (search report)
See references of WO 2012004258A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2012004258 A1 20120112; WO 2012004258 A9 20120607; AU 2011275825 A1 20130207; BR 112013000596 A2 20190924; CA 2804470 A1 20120112; CL 2013000083 A1 20130412; CN 103097387 A 20130508; CN 103097387 B 20161102; CN 106977530 A 20170725; CR 20130008 A 20130718; CU 20130007 A7 20130628; DO P2013000007 A 20130430; EA 201390060 A1 20130730; EC SP13012379 A 20130228; EP 2590979 A1 20130515; EP 2682394 A1 20140108; EP 2708539 A1 20140319; JP 2013532162 A 20130815; JP 6114189 B2 20170412; KR 20130132393 A 20131204; MX 2013000198 A 20130128; PE 20130779 A1 20130621; SG 186749 A1 20130228; US 2014350020 A1 20141127; US 9216978 B2 20151222; ZA 201209434 B 20140226
DOCDB simple family (application)
EP 2011061305 W 20110705; AU 2011275825 A 20110705; BR 112013000596 A 20110705; CA 2804470 A 20110705; CL 2013000083 A 20130109; CN 201180043624 A 20110705; CN 201610884283 A 20110705; CR 20130008 A 20130108; CU 20130007 A 20130108; DO 2013000007 A 20130107; EA 201390060 A 20110705; EC SP13012379 A 20130109; EP 11732409 A 20110705; EP 13180879 A 20110705; EP 13180880 A 20110705; JP 2013517357 A 20110705; KR 20137003410 A 20110705; MX 2013000198 A 20110705; PE 2013000009 A 20110705; SG 2012093043 A 20110705; US 201113806425 A 20110705; ZA 201209434 A 20121212